[HTML][HTML] First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck …
Y Guo, Y Luo, Q Zhang, X Huang, Z Li, L Shen… - European Journal of …, 2021 - Elsevier
Background The EXTREME regimen (chemotherapy [CT; cisplatin/carboplatin and 5-
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
[PDF][PDF] First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck …
Y Guo, Y Luo, Q Zhang, X Huang, Z Li… - … Journal of Cancer, 2021 - openaccessrepository.it
Background: The EXTREME regimen (chemotherapy [CT; cisplatin/carboplatin and 5-
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy …
Y Guo, Y Luo, Q Zhang, X Huang, Z Li… - European Journal of …, 2021 - ejcancer.com
Background The EXTREME regimen (chemotherapy [CT; cisplatin/carboplatin and 5-
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy …
Y Guo, Y Luo, Q Zhang, X Huang, Z Li… - European Journal of …, 2021 - europepmc.org
Background The EXTREME regimen (chemotherapy [CT; cisplatin/carboplatin and 5-
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy …
Y Guo, Y Luo, Q Zhang, X Huang… - … journal of cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The EXTREME regimen (chemotherapy [CT; cisplatin/carboplatin and 5-
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
[PDF][PDF] First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck …
Y Guo, Y Luo, Q Zhang, X Huang, Z Li… - … Journal of Cancer, 2021 - openaccessrepository.it
Background: The EXTREME regimen (chemotherapy [CT; cisplatin/carboplatin and 5-
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …
fluorouracil]) plus cetuximab is a standard-of-care first-line (1L) treatment for patients with …